Rayno Life Science Stocks: Up 30%+ YTD After A Volatile October
Investors Whipsawed By V-Shaped Rally NASDAQ at New Highs 4631 DOW at New Highs 17,390 Investors got what was forecasted-a volatile October that moved from fear to greed in two weeks! The market was buffeted by the Ebola scare, macro analysts decrying easy money from the FED and a potential...
Sierra SnowBlog Oct. 2014: White Is the New Orange
Update 11/5/14 No storms on the horizon for next week in the West, but check out this model for a "polar express" in the East and Midwest also creating a "blocking pattern" for the West: http://wxbrad.com/massive-storm-in-the-pacific-drives-arctic-outbreak-into-the-u-s-next-week/ Massive Storm...
Bio Investor Forum #2: T-Cell Therapies and Cancer Targets
Genetically Modified T-cells: Gene Therapy Is Back! Here are some quick notes and an overview of the companies at Bio: Immuno-Oncology is one of the hottest new areas of biopharmaceutical development and on October 7 BIO presented a Therapeutic Session on "T-Cell Therapies: Best Bets in...
Rayno Life Science Performance: Up 21%+ YTD…FBT, GILD, ILMN
Biotechs Continue To Lead The Market NASDAQ registered its third day of gains up 2.38% for the period and life science stocks followed. The NAZ is now up 3.34% YTD. Biotech stocks are way ahead of the market YTD with our top ETF pick (FBT) up 31% YTD and 3.66% over five days.The IBB is up...
Trading A Bottom in Small Cap Life Science Stocks …Update 11/5
11/15/14 Speculative Small Cap Stocks-Stay Away Unless Your Are A Trader Nice profits were booked on our recent small cap picks but today the sell-off was "pronounced": Celldex (CLDX) was down 21% to $13.10 after hitting a high near $18 on October 31. GlycoMimetics (GLYC) was up 2.14% to $7.62...